Solstein Capital’s MetLife MET Stock Holding History

Solstein Capital’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-450	Closed	-$23K	–	334
2019 Q4	$23K	Buy	+450	New	+$21.7K	0.05%	175

Other funds holding MET

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Solstein Capital's MET Position: Q1 2020 in Review

Solstein Capital sold out of MetLife (MET) in Q1 2020, closing a stake of 450 shares — an estimated $23K sold.

Solstein Capital first reported a position in MET in Q4 2019 and held it in 1 quarter. The position peaked at $23K in Q4 2019. 963 funds tracked by Wall St. Rank hold MET as of Q1 2020.

Solstein Capital reported no remaining MetLife position as of Q1 2020 after selling out during the quarter.
Solstein Capital sold 450 MetLife shares in Q1 2020, an estimated $23K.
Solstein Capital first reported a position in MetLife in Q4 2019 and held it in 1 quarter.
Solstein Capital's MetLife position peaked at $23K in Q4 2019.
963 funds tracked by Wall St. Rank held MetLife as of Q1 2020.

Based on Solstein Capital's 13F filing for Q1 2020, filed 12 May 2020.